Population
4,188 subjects newly starting warfarin for atrial fibrillation in the Anticoagulation and Risk Factors in…
Design
Cohort
Follow-up
1 year
Authors
Loading...
High discontinuation rates highlight adherence challenges in AF; leaves open whether targeted interventions improve persistence in younger or low-risk patients.
More than 1 in 4 patients newly starting warfarin for atrial fibrillation discontinue therapy within the first year, particularly younger patients, those with poor INR control, and those with lower stroke risk.
Fang et al. (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: